Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer
Clinical trial NCT05003752 · UNKNOWN
Trial details
- NCT number
- NCT05003752
- Sponsor
- German Oncology Center, Cyprus
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2022-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.